Pharmacy Pearls: Trelegy Ellipta for COPD

Pharmacy Pearls: Trelegy Ellipta for COPD

December 3rd, 2021 | Asthma/COPDPharmacy Pearls

In this edition of Pharmacy Pearls, we review the use of Trelegy Ellipta for COPD, including some of the clinical trial outcomes that demonstrate benefits of triple therapy and which patients might be appropriate for triple therapy. You will also find dosing information and potential benefits for switching patients from multiple inhalers to Trelegy Ellipta.

As always, we welcome any questions or feedback you may have. Just email the Pharmacy Team.

Loader Loading...
EAD Logo Taking too long?

Reload Reload document
| Open Open in new tab

Download PDF [164.20 KB]